Atlas Trials

Primary Sclerosing Cholangitis (PSC)

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Sclerosing Cholangitis (PSC)

RecordFirmDate
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159 (NCT05082779)Cascade Pharmaceuticals, Inc2021-10-26
Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects (NCT06037577)ChemomAb Ltd.2019-03-05
Cholangioscopy in Primary Sclerosing Cholangitis (PSC) (NCT03766035)Boston Scientific Corporation2018-12-06
A POC and Dose-Ranging Study of HTD1801 in PSC Patients (NCT03333928)HighTide Biopharma Pty Ltd2018-02-09
Swiss Primary Sclerosing Cholangitis Cohort Study (NCT03146936)Fondazione Epatocentro Ticino2017-02-28
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function (NCT02808312)Gilead Sciences2016-07-13
Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) (NCT06767605)Asociación Española para el Estudio del Hígado2016-01-01
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) (NCT02177136)Intercept Pharmaceuticals2015-02-09
Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis (NCT02061540)Mirum Pharmaceuticals, Inc.2014-03-01
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) (NCT01672853)Gilead Sciences2013-03-04
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease (NCT01819766)Exact Sciences Corporation2013-03-01
A Pilot Study of Xifaxan to Treat Patients With PSC (NCT01695174)Mayo Clinic2012-08-01
Genomics of Primary Sclerosing Cholangitis (PSC) (NCT01161992)Mayo Clinic2002-03-01

Track Primary Sclerosing Cholangitis (PSC) automatically

Every clearance here is in the API, with alerts when new ones post.